Sumitomo Chemical Co (JP:4005) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sumitomo Chemical Co. is set to transfer its shares in Nihon Medi-Physics Co. to GE HealthCare Ltd., expecting significant gains in its financial statements as a result. This strategic move aims to leverage GE HealthCare’s global expertise to boost Nihon Medi-Physics’ growth and competitiveness in the radiopharmaceuticals sector. The transfer, which will finalize by March 31, 2025, is anticipated to add approximately 30 billion yen to Sumitomo’s operating income.
For further insights into JP:4005 stock, check out TipRanks’ Stock Analysis page.
